Janux Therapeutics Inc (JANX)

SG&A Expense Growth

-1.53%

Quarterly · Period ending:

JANX logo

JANX SG&A Expense Growth

Latest reported-1.53%
JANX Quarterly SG&A Growth (QoQ) (0.00% → -1.53%)
High-resolution chart · PNG

JANX sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Janux Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-1.527%
2.5799%
2.1747%
1.607%
6.2182%
19.7907%
-53.4952%
125.8918%
14.829%
7.1417%
-1.2582%
-6.438%
6.4511%
13.863%
-6.9039%
10.0722%
11.9871%
25.6541%
7.686%
83.0746%
170.23%
10.2985%
58.7678%
-2.5404%
56.3177%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.